IL155400A0 - Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof - Google Patents
Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereofInfo
- Publication number
- IL155400A0 IL155400A0 IL15540001A IL15540001A IL155400A0 IL 155400 A0 IL155400 A0 IL 155400A0 IL 15540001 A IL15540001 A IL 15540001A IL 15540001 A IL15540001 A IL 15540001A IL 155400 A0 IL155400 A0 IL 155400A0
- Authority
- IL
- Israel
- Prior art keywords
- venlafaxine
- preparing
- processes
- crystalline
- base
- Prior art date
Links
- 229960004688 venlafaxine Drugs 0.000 title 1
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 title 1
- 229960002416 venlafaxine hydrochloride Drugs 0.000 title 1
- QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/10—Separation; Purification; Stabilisation; Use of additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24157700P | 2000-10-19 | 2000-10-19 | |
US25886100P | 2000-12-29 | 2000-12-29 | |
US27872101P | 2001-03-26 | 2001-03-26 | |
US29246901P | 2001-05-21 | 2001-05-21 | |
PCT/US2001/051017 WO2002045658A2 (fr) | 2000-10-19 | 2001-10-19 | Base cristalline de venlafaxine et nouveaux polymorphes de chlorhydrate de venlafaxine, et preparation de ceux-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
IL155400A0 true IL155400A0 (en) | 2003-11-23 |
Family
ID=27500045
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15540001A IL155400A0 (en) | 2000-10-19 | 2001-10-19 | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof |
IL196287A IL196287A0 (en) | 2000-10-19 | 2008-12-31 | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL196287A IL196287A0 (en) | 2000-10-19 | 2008-12-31 | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof |
Country Status (20)
Country | Link |
---|---|
US (1) | US20020143211A1 (fr) |
EP (1) | EP1334082A4 (fr) |
JP (2) | JP2004530638A (fr) |
KR (1) | KR20030059206A (fr) |
CN (1) | CN1620420A (fr) |
AU (1) | AU2002241764A1 (fr) |
CA (1) | CA2426158A1 (fr) |
CZ (1) | CZ20031298A3 (fr) |
DE (1) | DE01988460T1 (fr) |
ES (1) | ES2206082T1 (fr) |
HR (1) | HRP20030392A2 (fr) |
HU (1) | HUP0303496A3 (fr) |
IL (2) | IL155400A0 (fr) |
IS (1) | IS6789A (fr) |
MX (1) | MXPA03003459A (fr) |
NO (1) | NO20031743L (fr) |
PL (1) | PL365895A1 (fr) |
SK (1) | SK5762003A3 (fr) |
WO (1) | WO2002045658A2 (fr) |
YU (1) | YU30203A (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020183553A1 (en) * | 2000-10-19 | 2002-12-05 | Ben-Zion Dolitzky | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
EP1330427A1 (fr) * | 2000-10-31 | 2003-07-30 | Ciba SC Holding AG | Formes cristallines de chlorhydrate de venlafaxine |
HUP0104872A3 (en) * | 2001-11-13 | 2004-04-28 | Egis Gyogyszergyar Nyilvanosan | New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use |
UA77234C2 (en) * | 2001-12-05 | 2006-11-15 | Wyeth Corp | Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants) |
KR20050044673A (ko) | 2001-12-05 | 2005-05-12 | 와이어쓰 | 벤라팍신 하이드로클로라이드의 신규한 결정 다형체 및이의 제조방법 |
WO2003050074A1 (fr) * | 2001-12-13 | 2003-06-19 | Cadila Healthcare Limited | Fabrication de l'hydrochlorure venlafaxine et de polymorphes cristallins de celui-ci |
AU2003226748A1 (en) * | 2002-03-28 | 2003-10-13 | Synthon B.V. | Compositions of venlafaxine base |
AR039163A1 (es) | 2002-03-28 | 2005-02-09 | Synthon Bv | Besilato de venlafaxina |
WO2003082805A1 (fr) | 2002-03-28 | 2003-10-09 | Synthon B.V. | Sels de venlafaxine faiblement solubles dans l'eau |
DE10359154A1 (de) | 2003-12-16 | 2005-07-28 | Krka Tovarna Zdravil, D.D. | Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I |
US7468428B2 (en) | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
JP4889501B2 (ja) * | 2004-10-20 | 2012-03-07 | 田辺三菱製薬株式会社 | フェニルエタノールアミン化合物の製造方法及びその中間体 |
KR20080056311A (ko) * | 2005-10-19 | 2008-06-20 | 테바 파마슈티컬 인더스트리즈 리미티드 | 고순도1-[2-디메틸아미노-(4-메톡시페닐)에틸)시클로헥산올염산염의 제조 방법 |
WO2007049302A2 (fr) * | 2005-10-28 | 2007-05-03 | Ind-Swift Laboratories Limited | Procede ameliore pour la preparation de venlafaxine pure |
SI2032521T1 (sl) | 2006-06-27 | 2010-02-26 | Sandoz Ag | Nov postopek za pripravo soli |
EP2081885A2 (fr) * | 2006-07-14 | 2009-07-29 | Medichem, S.A. | Procedes ameliores servant a preparer de la venlafaxine sous forme de base et des sels de celle-ci |
CA2860747C (fr) * | 2010-10-01 | 2015-08-11 | Shan Dong Luye Pharmaceutical Co., Ltd. | Formes polymorphiques du chlorhydrate de 4-methylbenzoate de 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyle, leurs procedes de synthese et leur utilisation |
AU2014348523B2 (en) | 2013-11-15 | 2019-01-03 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
US4611078A (en) * | 1983-10-26 | 1986-09-09 | American Home Products Corporation | Substituted phenylacetonitriles |
AR255595A1 (fr) | 1994-07-13 | 2002-05-24 | Gador Sa | |
PE57198A1 (es) * | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
US6197828B1 (en) * | 1998-12-01 | 2001-03-06 | Sepracor, Inc. | Derivatives of (+)-venlafaxine and methods of preparing and using the same |
US20020183553A1 (en) * | 2000-10-19 | 2002-12-05 | Ben-Zion Dolitzky | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
EP1330427A1 (fr) * | 2000-10-31 | 2003-07-30 | Ciba SC Holding AG | Formes cristallines de chlorhydrate de venlafaxine |
AU2001235970A1 (en) * | 2000-12-07 | 2002-06-18 | Dr. Reddy's Research Foundation | Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation |
-
2001
- 2001-10-19 SK SK576-2003A patent/SK5762003A3/sk not_active Application Discontinuation
- 2001-10-19 HU HU0303496A patent/HUP0303496A3/hu unknown
- 2001-10-19 EP EP01988460A patent/EP1334082A4/fr not_active Withdrawn
- 2001-10-19 MX MXPA03003459A patent/MXPA03003459A/es unknown
- 2001-10-19 ES ES01988460T patent/ES2206082T1/es active Pending
- 2001-10-19 CN CNA018208185A patent/CN1620420A/zh active Pending
- 2001-10-19 IL IL15540001A patent/IL155400A0/xx unknown
- 2001-10-19 CZ CZ20031298A patent/CZ20031298A3/cs unknown
- 2001-10-19 CA CA002426158A patent/CA2426158A1/fr not_active Abandoned
- 2001-10-19 DE DE0001334082T patent/DE01988460T1/de active Pending
- 2001-10-19 YU YU30203A patent/YU30203A/sh unknown
- 2001-10-19 JP JP2002547444A patent/JP2004530638A/ja active Pending
- 2001-10-19 PL PL01365895A patent/PL365895A1/xx not_active Application Discontinuation
- 2001-10-19 US US10/045,510 patent/US20020143211A1/en not_active Abandoned
- 2001-10-19 KR KR10-2003-7005447A patent/KR20030059206A/ko not_active Application Discontinuation
- 2001-10-19 WO PCT/US2001/051017 patent/WO2002045658A2/fr active Application Filing
- 2001-10-19 AU AU2002241764A patent/AU2002241764A1/en not_active Abandoned
-
2003
- 2003-04-15 IS IS6789A patent/IS6789A/is unknown
- 2003-04-15 NO NO20031743A patent/NO20031743L/no not_active Application Discontinuation
- 2003-05-15 HR HR20030392A patent/HRP20030392A2/hr not_active Application Discontinuation
-
2008
- 2008-04-30 JP JP2008119070A patent/JP2008239629A/ja active Pending
- 2008-12-31 IL IL196287A patent/IL196287A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0303496A2 (hu) | 2004-01-28 |
AU2002241764A1 (en) | 2002-06-18 |
NO20031743L (no) | 2003-06-18 |
KR20030059206A (ko) | 2003-07-07 |
WO2002045658A2 (fr) | 2002-06-13 |
ES2206082T1 (es) | 2004-05-16 |
DE01988460T1 (de) | 2004-04-22 |
IL196287A0 (en) | 2011-08-01 |
JP2004530638A (ja) | 2004-10-07 |
EP1334082A4 (fr) | 2006-02-01 |
NO20031743D0 (no) | 2003-04-15 |
SK5762003A3 (en) | 2003-11-04 |
HRP20030392A2 (en) | 2005-04-30 |
WO2002045658A3 (fr) | 2003-01-16 |
CA2426158A1 (fr) | 2002-06-13 |
MXPA03003459A (es) | 2005-04-29 |
IS6789A (is) | 2003-04-15 |
YU30203A (sh) | 2006-08-17 |
HUP0303496A3 (en) | 2005-08-29 |
CZ20031298A3 (cs) | 2003-10-15 |
US20020143211A1 (en) | 2002-10-03 |
JP2008239629A (ja) | 2008-10-09 |
CN1620420A (zh) | 2005-05-25 |
PL365895A1 (en) | 2005-01-10 |
EP1334082A2 (fr) | 2003-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL196287A0 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof | |
EP1463711A4 (fr) | Nouveau polymorphe d'hydrochlorure de sertraline et compositions contenant celui-ci, nouvelles methodes de preparation de polymorphes d'hydrochlorure de sertraline et forme amorphe associee | |
IL149050A0 (en) | Polymorphic forms of sertraline hydrochloride | |
HK1067123A1 (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and processes for their preparation | |
HUP0204010A3 (en) | Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and their use | |
AU1234002A (en) | Crystalline forms of venlafaxine hydrochloride | |
IL162171A0 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof | |
EP1289928A4 (fr) | Nouvelle forme amorphe d'hydrochlorure de sertraline | |
HUP0400299A2 (en) | Polymorphs of fexofenadine hydrochloride | |
IL162255A0 (en) | Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof | |
AU2001235970A1 (en) | Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation | |
IL159266A (en) | Crystalline forms of fexofenadine and processes for the preparation thereof | |
AU2002247945A1 (en) | Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof | |
PL2181982T3 (pl) | Sposób wytwarzania chlorowodorku wenlafaksyny w formie I | |
AU2003297640A8 (en) | Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof | |
HUP0302144A3 (en) | Process of preparation of aliphatic amines | |
PL372137A1 (en) | A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form | |
PL376832A1 (pl) | Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny | |
AU2003243153A8 (en) | Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof | |
AU2002308095A1 (en) | Process for preparing sertraline hydrochloride polymorphic form ii | |
IL161816A0 (en) | Polymorphs of fexofenadine base | |
IL140632A0 (en) | A novel process for the preparation of paroxetine and novel intermediates thereof |